Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $446.4 million specializing in mRNA therapeutics and vaccines, stands at a ...

North Carolina achieved a record-breaking year for life sciences investments in 2024. Twenty-five companies announced ...

Experts in every field of medical research gather at meetings to decide which topics and projects are most deserving of funds ...

CRANBURY, NEW JERSEY / ACCESS Newswire / January 28, 2025 / AcceleDev Chemical LLC, a leading contract development and manufacturing organization (CDMO) specializing in custom synthesis and process de ...

Mart Loog secured a €15 million grant from the Council of Europe to develop Estonia's biotechnology landscape. However, last ...

The Trump administration is freezing all National Institutes of Health research grants, potentially throwing sand into a ...

The startup says its specially constructed RNAi therapies can get deep into brain tissue, yielding new ways to treat neurological conditions like Huntington’s.

The freeze, even if it ends up only lasting a few weeks, would hit St. Louis particularly hard. In addition to WashU, St.

Scientists have unveiled a groundbreaking method to test how thousands of active substances influence cellular metabolism ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

Researchers are worried about the federal cancellation of meetings last week which are key to hundreds of millions in funding ...

The Minister set an ambitious goal for CSIR-IITR to expand its reach, aligning with the vision of Viksit Bharat to ensure a ...